Moving beyond the traditional pharma-provider relationship

Healthcare has long recognized that no single organization can solve its biggest challenges alone. As patient needs become more complex and pressures on healthcare systems continue to grow, strategic partnerships have become an increasingly important way to improve care delivery, expand access, and drive meaningful outcomes.

Health systems now routinely collaborate with consulting firms, technology companies, medical device manufacturers, and digital health organizations to address challenges ranging from operational efficiency to clinical transformation. These relationships have evolved beyond traditional vendor models into partnerships built around shared objectives, complementary expertise, and measurable impact.

Yet one important stakeholder has largely remained outside this evolution.

While relationships between healthcare providers and pharma companies have historically centered on therapies, education, market access, and reimbursement support, there is growing opportunity to rethink how these organizations work together. As healthcare becomes increasingly interconnected, strategic partnerships between providers and pharma companies represent the next frontier in collaborative healthcare.

What strategic partnerships could look like

Traditional pharma-provider engagement has created significant value, particularly through scientific exchange, clinician education, patient support services, and research collaboration. However, many of today's healthcare challenges extend beyond the reach of any single product or organization.

The next generation of relationships between pharma and providers has the potential to focus on broader system challenges that influence patient outcomes, including care coordination, patient navigation, referral pathway development, access to diagnostics, provider education, operational efficiency, and community engagement.

Rather than supporting individual therapies alone, these strategic partnerships can help healthcare organizations strengthen the systems that enable patients to receive timely, coordinated, high-quality care.

A compelling model for this type of collaboration is the partnership between The START Center for Cancer Research, a leading network of early-stage cancer research, and OneOncology, a physician-led oncology platform. [source] Together, the organizations expanded access to early-phase clinical trials by bringing research infrastructure directly into community oncology practices. Historically, patients interested in participating in innovative clinical research often needed to travel to large academic centers, creating significant barriers to access. By embedding trial capabilities within community settings, the partnership expanded research opportunities for patients, strengthened provider capabilities, and improved access to innovation.

The partnership demonstrates what is possible when organizations align around a shared objective and combine complementary expertise to solve challenges that benefit the broader healthcare ecosystem. While this example is rooted in oncology, the underlying principle extends across therapeutic areas: organizations can create greater impact by collaborating around shared healthcare challenges rather than individual organizational interests. For life sciences companies, this represents a compelling model for future strategic partnerships—strengthening care delivery, improving patient experience, and creating value well beyond the product itself.

Creating shared value

The strongest strategic partnerships create value for every stakeholder involved. When organizations align around shared healthcare challenges rather than individual organizational objectives, the benefits extend well beyond the partnership itself.

For patients

Strategic partnerships can help address many of the barriers that exist outside the clinical encounter, including transportation challenges, insurance complexity, financial burden, health literacy, and awareness of available treatment options. By combining resources, expertise, and coordinated support, these collaborations can create a more connected patient experience and improve access to timely, appropriate care.

For healthcare organizations and providers

Healthcare organizations benefit from additional expertise and resources that support improved care delivery. Strategic partnerships can strengthen access to diagnostics, enhance care coordination, improve operational efficiency, reduce administrative burden, expand patient support services, and generate real-world evidence that informs future care delivery. Ultimately, these collaborations allow care teams to devote more time to patients and less time navigating operational challenges.

For pharma companies

For pharma organizations, strategic partnerships offer an opportunity to expand their impact beyond developing innovative therapies. By working alongside healthcare organizations to address broader challenges in care delivery, companies can help improve earlier diagnosis, accelerate access to treatment, reduce barriers to care, and strengthen the overall patient experience.

Perhaps more importantly, these collaborations provide deeper insight into the realities of healthcare delivery, enabling pharma companies to better understand unmet needs and develop solutions that create meaningful, measurable value for the healthcare ecosystem as a whole.

Designing successful strategic partnerships

Turning strategic partnerships into measurable impact requires thoughtful planning and shared commitment. While every collaboration is different, several foundational principles consistently contribute to success:

• Shared purpose and stakeholder alignment: Successful partnerships begin with clearly defined goals, transparent governance, and agreement on the outcomes all stakeholders are working toward.

• Meaningful unmet needs: The greatest impact comes from addressing challenges that matter most to patients, providers, and healthcare organizations—not simply launching programs because they are possible.

• Data and measurement: Effective partnerships require access to meaningful insights and clearly defined success metrics that demonstrate both clinical and operational impact.

• Compliance and governance: Strong governance structures ensure collaborations remain transparent, compliant, and focused on delivering value.

• Long-term sustainability: Lasting change requires dedicated ownership, appropriate resources, and integration into existing healthcare workflows rather than stand-alone initiatives.

These principles apply across virtually every therapeutic area. As healthcare continues evolving toward more integrated, value-based models of care, organizations that build partnerships around shared outcomes rather than individual interests will be better positioned to create lasting impact.

The opportunity ahead

Strategic partnerships represent a natural evolution in how healthcare organizations and pharma companies work together. Rather than focusing solely on supporting treatments, the next generation of collaborations has the potential to address the broader operational, clinical, and patient experience challenges that ultimately determine whether innovation reaches the people who need it most.

Nowhere is this opportunity more evident than in highly complex disease areas that depend on multidisciplinary care. Hematology-oncology is one such example. Caring for patients with blood cancers often requires close coordination between oncologists, hematologists, pathologists, pharmacists, nurse navigators, transplant specialists, and academic referral centers, while treatment decisions increasingly rely on biomarker testing, genomic profiling, advanced therapies, and clinical trial access. Success depends not only on having innovative therapies available, but on ensuring that patients can move efficiently through an increasingly complex care journey.

These are precisely the kinds of challenges that strategic partnerships are uniquely positioned to address. By aligning expertise, resources, and shared objectives across stakeholders, pharma companies and healthcare organizations can help strengthen the systems surrounding patient care—not just the treatments within them.

As healthcare continues to become more personalized, multidisciplinary, and operationally complex, the organizations that embrace strategic collaboration will be best positioned to improve outcomes for patients while creating lasting value across the healthcare ecosystem.

Every healthcare challenge is unique—and so is every strategic partnership.

Whether you'd like to brainstorm partnership opportunities together around a specific challenge or have our team assess your objectives and recommend a strategic partnership approach, M Health can help identify practical, measurable solutions that create value for patients, providers, and pharma organizations.